At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...